Her phenotype was consistent with CMT4 and the only gene within a region of homozygosity consistent with this was SBF2. No variants in SBF2 were found on initial automated bioinformatic analysis, or on a previously performed targeted neuropathy gene panel. This evidence concerns the gene GDAP1 and neuropathy.